Thiazolidinediones/insulin use and cancer risk: Insights from the recent meta-analyses

被引：1
作者：
Simon, D. [1 ,2 ,3 ]
机构：
[1] Hop La Pitie Salpetriere, AP HP, Serv Diabetol, F-75013 Paris, France
[2] Univ Paris 06, Paris, France
[3] INSERM CESP, U1018, F-94800 Villejuif, France
来源：
DIABETES & METABOLISM | 2013年 / 39卷 / 01期
关键词：
Type; 2; diabetes; Thiazolidinediones; Pioglitazone; Insulin; Glargine; Cancer; Meta-analysis; BLADDER-CANCER; PIOGLITAZONE; INSULIN; COHORT;
D O I：
10.1016/j.diabet.2013.01.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 5
页数：3
相关论文
共 18 条
  • [1] Cohen SM, 1999, IARC SCI PUBL, P175
  • [2] Insulin use and cancer risk in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies
    Colmers, I. N.
    Bowker, S. L.
    Tjosvold, L. A.
    Johnson, J. A.
    [J]. DIABETES & METABOLISM, 2012, 38 (06) : 485 - 506
  • [3] Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
    Colmers, I. N.
    Bowker, S. L.
    Johnson, J. A.
    [J]. DIABETES & METABOLISM, 2012, 38 (06) : 475 - 484
  • [4] Colmers IN, 2012, CMAJ, V184, P675
  • [5] No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
    Dejgaard, A.
    Lynggaard, H.
    Rastam, J.
    Thomsen, M. Krogsgaard
    [J]. DIABETOLOGIA, 2009, 52 (12) : 2507 - 2512
  • [6] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
    Dormandy, JA
    Charbonnel, B
    Eckland, DJA
    Erdmann, E
    Massi-Benedetti, M
    Kmoules, IK
    Skene, AM
    Tan, MH
    Lefébvre, PJ
    Murray, GD
    Standl, E
    Wilcox, RG
    Wlhelmsen, L
    Betteridge, J
    Birkeland, K
    Golay, A
    Heine, RJ
    Korányi, L
    Laakso, M
    Mokán, M
    Norkus, A
    Pirags, V
    Podar, T
    Scheen, A
    Scherbaum, W
    Schernthaner, G
    Schmitz, O
    Skrha, J
    Smith, U
    Taton, J
    [J]. LANCET, 2005, 366 (9493) : 1279 - 1289
  • [7] Proliferative and Molecular Effects of the Dual PPARα/γ Agonist Tesaglitazar in Rat Adipose Tissues: Relevance for Induction of Fibrosarcoma
    Glinghammar, Bjorn
    Berg, Anna-Lena
    Bjurstrom, Sivert
    Stockling, Kenneth
    Blomgren, Bo
    Westerberg, Rolf
    Skanberg, Inger
    Hellmold, Heike
    Andersson, Ulf
    [J]. TOXICOLOGIC PATHOLOGY, 2011, 39 (02) : 325 - 336
  • [8] Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
    Hemkens, L. G.
    Grouven, U.
    Bender, R.
    Guenster, C.
    Gutschmidt, S.
    Selke, G. W.
    Sawicki, P. T.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1732 - 1744
  • [9] Hillaire-Buys D, 2011, LANCET, V378, P1543, DOI 10.1016/S0140-6736(11)61662-0
  • [10] Combined randomised controlled trial experience of malignancies in studies using insulin glargine
    Home, P. D.
    Lagarenne, P.
    [J]. DIABETOLOGIA, 2009, 52 (12) : 2499 - 2506
12